Neurol. praxi. 2011;12(3):181-187

Acute polyradiculoneuritis - differential diagnostics

doc.MUDr.Edvard Ehler, CSc.1, MUDr.Magdalena Derďáková1,2, MUDr.Ján Latta1, MUDr.Milan Mrklovský3
1 Neurologická klinika PKN, a. s. a FZS Univerzita Pardubice
2 Neurologické oddělení, Litomyšlská nemocnice, Litomyšl
3 Radiodiagnostické oddělení PKN a. s. a Multiscan s. r. o., Pardubice

Acute polyradiculoneuritis is an autoimmune-based neuropathy and represents an important diagnostic and therapeutic problem. In Europe

demyelinating forms prevail (more than 80 %), whereas in China and in Middle and Southern America the axonal forms represent more

important portion. During diagnosis setting there is necessary to evaluate clinical finding and a course of disease, then laboratory analysis

of blood and urine follow, further electrophysiological investigations (motor and sensory neurography, F-waves, H-reflex) and withdrawal

of cerebrospinal fluid. During differential diagnostic process there is to evaluate and differentiate a couple of various disoders.

dissociation.

Keywords: acute polyradiculoneuritis, molecular mimicry, demyelination, axonopathy, electrophysiological investigation, proteincytological

Published: June 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ehler E, Derďáková M, Latta J, Mrklovský M. Acute polyradiculoneuritis - differential diagnostics. Neurol. praxi. 2011;12(3):181-187.
Download citation

References

  1. Alshekhlee A, Hussain Z, Sultan B, Katirji B. Guillain-Barré syndrome: incidence and mortality rates in US hospitals. Neurology 2008; 70(18): 1608-1613. Go to original source... Go to PubMed...
  2. Amato AA, Russel JA (Eds). Neuromuscular disorders. New York: Mc Graw Hill 2008: 775.
  3. Ambler Z. Akutní polyneuropatie. Ces Slov Neurol Neurochir 2006; 1: 4-16.
  4. Bednařík J, Lukáš Z, Vondráček P. Critical illness polyneuropathy: the electrophysiologic component of a complex entity.Intensive Care Med 2003; 29(9): 1505-1514. Go to original source... Go to PubMed...
  5. Bednařík J, Voháňka S, Ehler E, Ambler Z, Piťha J, Vencovský J, Litzner J, Kořístek Z, Suchý M, Pátá M, Kořený P. Standard pro léčbu pacientů s autoimunitními nervosvalovými onemocněními intravenózním lidským imunoblogulinem a plazmaferézou. Cesk Slov Neurol N 2010; 73/106(5): 570-589.
  6. Falchenecker P. Autonomic dysfunction in Guillain-Barré syndrome and multiple sclerosis. J Neurol 2007; 254(Suppl 2): 96-101. Go to original source... Go to PubMed...
  7. Feldman EL, Grisold W, Russell JW, Zifko UA. Atlas of neuromuscular diseases. Springer Wien New York, 2005: 474.
  8. Gordon PH, Wilbourn AJ. Early electrodiagnostic findings in Guillain-Barré syndrome. Arch Neurol 2001; 58: 913-918. Go to original source... Go to PubMed...
  9. Hadden RDM, Hughes RAC. Management of inflammatory neuropathies. J Neurol Neurosurg Psychiatry 2003; 74(Suppl 2): 9-14. Go to original source... Go to PubMed...
  10. Hughes RAC, Cornblath CR. Guillain-Barré syndrome. Lancet 2005; 366, 9497: 1653-1665. Go to original source... Go to PubMed...
  11. Hughes RAC, Swan AV, Raphaël JC, Annane D, van Koningsveld R, van Doorn PA. Immunotherapy for Guillain-Barré syndrome: a systematic review. Brain 2007; 130: 2245-2257. Go to original source... Go to PubMed...
  12. Kusunoki S, Kaida K. Antibodies against ganglioside complexes in Guillain-Barré syndrome and related disorders. J Neurochem 2011; Jan 7.doi: 10.1111/j.14714159.2010.07029x. Go to original source... Go to PubMed...
  13. Lawn ND, Fletcher DD, Henderson RD, Wolter TD, Wijdicks EF. Anticipation mechanical ventilation in Guillain-Barré syndrome. Arch Neurol 2001; 58(6): 871-872. Go to original source... Go to PubMed...
  14. Layon AJ, Gabrielli A, Friedman WA. Textbook of neurointensive care. Philadelphia: Saunders 2004: 907.
  15. Levin K. Diseases of the nerve roots. Continuum 2008; 14(3): 134-155. Go to original source...
  16. Mendell JR, Kissel JT, Cornblath DR. Diagnosis and management of peripheral nerve disorders. Oxford: Oxford University Press 2001: 695.
  17. Minks E, Bareš M. Elektromyografická diagnostika u akutní zánětlivé demyelinizační polyradikuloneuritidy. Retrospektivní hodnocení a srovnání s mezinárodními kritérii. Neurol praxi 2007; 1: 43-48.
  18. Oh SJ. (Ed.) Principles of clinical electromyography. Case studies. Baltimore: Williams Wilkins 1998: 604.
  19. Pourmand R (Ed). Immune-mediated neuromuscular diseases. Basel: Karger 2009: 170. Go to original source...
  20. Ryan MM. Guillain-Barré syndrome in childhood. J Pediatr Child Health 2005; 41: 237-241. Go to original source... Go to PubMed...
  21. Steiner I, Wirguin I, Blumen SC, Dano M, Raphaeli G, Schwartz I, Korn-Lubetzki I., ,Hyperacute" Guillain-Barré syndrome. Eur Neurol 2008; 59: 88-90. Go to original source... Go to PubMed...
  22. The Italian Guillain-Barré Study Group: The prognosis and the main prognostic indicators of Guillain-Barré syndrome: a multicentre prospective study of 297 patients. Brain 1996; 119: 2053-2061. Go to original source... Go to PubMed...
  23. van Doorn PA, Kuitwaard K, Walgaard C, van Koningsveld R. IVIG treatment and prognosis in Guillain-Barré syndrome. J Clin Immun 2010; 30: 74-81. Go to original source... Go to PubMed...
  24. van Doorn PA, Ruts L, Jacob BC. Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome. Lancet Neurol 2008; 7: 939-950. Go to original source... Go to PubMed...
  25. Yuki N, Kuwabara S. Axonal Guillain-Barré syndrome: carbohydrate mimicry and pathophysiology. J Periph Nervous System 2007; 12: 238-249. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.